Agilent Technologies, Inc. $A Shares Sold by T. Rowe Price Investment Management Inc.

Key Points

• T. Rowe Price Investment Management Inc. reduced its stake in Agilent Technologies by 7.6%, owning approximately 2.67% of the company post-sale.
• Agilent Technologies received several analyst upgrades, with price targets ranging from $125.00 to $150.00 and a consensus rating of "Moderate Buy."
• The company recently announced a $0.248 quarterly dividend, representing a 0.8% yield and a 24.44% dividend payout ratio.

T. Rowe Price Investment Management Inc. decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 7.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,599,291 shares of the medical research company's stock after selling 629,164 shares during the period. T. Rowe Price Investment Management Inc. owned approximately 2.67% of Agilent Technologies worth $888,966,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Sunbelt Securities Inc. grew its stake in shares of Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after buying an additional 192 shares in the last quarter. Whipplewood Advisors LLC grew its stake in shares of Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after buying an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at $34,000. Stone House Investment Management LLC bought a new position in shares of Agilent Technologies in the first quarter valued at $30,000. Finally, Opal Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the first quarter valued at $31,000.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the sale, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Agilent Technologies Stock Performance

Shares of A stock traded down $2.3580 during mid-day trading on Monday, reaching $119.2720. The stock had a trading volume of 438,647 shares, compared to its average volume of 1,936,749. The business's fifty day moving average is $117.88 and its 200-day moving average is $117.05. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The firm has a market cap of $33.88 billion, a price-to-earnings ratio of 29.52, a PEG ratio of 3.69 and a beta of 1.22. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm's quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.22 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Robert W. Baird cut their target price on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research note on Thursday, May 22nd. Leerink Partners boosted their target price on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Friday, May 30th. Evercore ISI raised their price target on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research note on Thursday, May 29th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average target price of $139.77.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.